CAD 0.09
(-5.26%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | - CAD | 100.0% |
2022 | -18.43 Thousand CAD | 0.01% |
2021 | -18.43 Thousand CAD | -80731.29% |
2020 | -22.81 CAD | 73.45% |
2019 | -85.90 CAD | 99.99% |
2018 | -1.13 Million CAD | -3408.42% |
2017 | -32.38 Thousand CAD | 0.0% |
2016 | - CAD | 100.0% |
2015 | -417.39 CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 100.0% |
2008 | -500 Thousand CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | - CAD | 0.0% |
2024 Q2 | - CAD | 0.0% |
2023 Q3 | - CAD | 0.0% |
2023 Q2 | - CAD | 0.0% |
2023 Q1 | - CAD | 100.0% |
2023 Q4 | - CAD | 0.0% |
2023 FY | - CAD | 100.0% |
2022 Q4 | -4608.00 CAD | 0.02% |
2022 Q1 | -4609.00 CAD | 0.0% |
2022 Q2 | -4609.00 CAD | 0.0% |
2022 Q3 | -4609.00 CAD | 0.0% |
2022 FY | -18.43 Thousand CAD | 0.01% |
2021 Q2 | -4609.00 CAD | 0.0% |
2021 FY | -18.43 Thousand CAD | -80731.29% |
2021 Q1 | -4609.00 CAD | 30.17% |
2021 Q3 | -4609.00 CAD | 0.0% |
2021 Q4 | -4609.00 CAD | 0.0% |
2020 Q2 | -65.74 Thousand CAD | 0.0% |
2020 Q1 | - CAD | 100.0% |
2020 Q4 | -6600.00 CAD | -32.26% |
2020 FY | -22.81 CAD | 73.45% |
2020 Q3 | -4990.00 CAD | 92.41% |
2019 FY | -85.90 CAD | 99.99% |
2019 Q1 | -39.96 Thousand CAD | 18.95% |
2019 Q4 | -34.52 Thousand CAD | -197.29% |
2019 Q3 | 35.48 Thousand CAD | 188.92% |
2019 Q2 | -39.9 Thousand CAD | 0.15% |
2018 Q2 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 Q4 | -49.3 Thousand CAD | -64.36% |
2018 Q3 | -30 Thousand CAD | 0.0% |
2018 FY | -1.13 Million CAD | -3408.42% |
2017 Q1 | - CAD | 0.0% |
2017 FY | -32.38 Thousand CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 FY | - CAD | 100.0% |
2016 Q4 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 FY | -417.39 CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2009 FY | - CAD | 100.0% |
2009 Q4 | - CAD | 0.0% |
2009 Q1 | - CAD | 0.0% |
2008 FY | -500 Thousand CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -50.39 Thousand CAD | 100.0% |
Asep Medical Holdings Inc | -113.74 Thousand CAD | 100.0% |
BioVaxys Technology Corp. | - CAD | NaN% |
ChitogenX Inc. | -42 Thousand CAD | 100.0% |
Rapid Dose Therapeutics Corp. | 563.4 Thousand CAD | 100.0% |
Defence Therapeutics Inc. | -90.92 Thousand CAD | 100.0% |
Entheon Biomedical Corp. | 250.32 Thousand CAD | 100.0% |
Gemina Laboratories Ltd. | -93.36 Thousand CAD | 100.0% |
Glow Lifetech Corp. | -505.62 Thousand CAD | 100.0% |
Lexston Life Sciences Corp. | -26.39 Thousand CAD | 100.0% |
Pharmala Biotech Holdings Inc. | 454.09 Thousand CAD | 100.0% |
Doseology Sciences Inc. | -36.08 Thousand CAD | 100.0% |
MYND Life Sciences Inc. | -332.99 Thousand CAD | 100.0% |
Nova Mentis Life Science Corp. | 25.4 Thousand CAD | 100.0% |
PharmaTher Holdings Ltd. | -711.00 CAD | 100.0% |
PreveCeutical Medical Inc. | -9856.00 CAD | 100.0% |
Telescope Innovations Corp. | 595.39 Thousand CAD | 100.0% |